EPFL2 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
EPFL2 antibody; At4g37810 antibody; T28I19.4EPIDERMAL PATTERNING FACTOR-like protein 2 antibody; EPF-like protein 2) [Cleaved into: MEPFL2] antibody
Target Names
EPFL2
Uniprot No.

Target Background

Function
This antibody targets a protein that regulates stomatal development.
Gene References Into Functions

The EPFL2 peptide's role in stomatal patterning is mediated through its interaction with ERECTA (ER) family receptor-kinases. Reduced ER activity, resulting from EPFL2 peptide function, leads to the development of leaves lacking teeth (toothless leaves). During tooth development, auxin signaling is maintained at the tooth tips to promote their growth.

Further details can be found in the following publication: PMID: 27593376

Database Links

KEGG: ath:AT4G37810

STRING: 3702.AT4G37810.1

UniGene: At.45312

Protein Families
Plant cysteine rich small secretory peptide family, Epidermal patterning factor subfamily
Subcellular Location
Secreted.

Q&A

What is EPFL2 and why is it significant in plant research?

EPFL2 (EPIDERMAL PATTERNING FACTOR-LIKE 2) is a member of the EPF/EPFL gene family that encodes plant-specific secreted peptides. These cysteine-rich peptides play crucial roles in cell-to-cell signaling pathways that control various developmental processes in plants. Specifically, EPFL2 has been identified as a key regulator in:

  • Growth of leaf teeth through interaction with ERECTA (ER) family receptor kinases

  • Ovule initiation and development in flowering plants

  • Boundary domain specification during embryogenesis

  • Cell fate specification during plant organ development

EPFL2 has gained significance in plant developmental biology due to its role in organizing auxin response during leaf margin morphogenesis and its contribution to reproductive development. Research with EPFL2 antibodies enables the visualization and quantification of this important signaling peptide in various developmental contexts.

What detection methods are most effective when working with EPFL2 antibodies?

Based on available research data, the most effective detection methods when working with EPFL2 antibodies include:

Detection MethodApplicationSensitivityBest For
ELISAQuantitative detectionHigh (pg-ng range)Protein quantification in tissue extracts
Western BlotProtein size verificationMediumConfirming specificity and protein expression
ImmunohistochemistrySpatial localizationMedium-HighVisualizing tissue-specific expression patterns

When designing experiments with EPFL2 antibodies, researchers should consider:

  • Using antigen affinity-purified antibodies to ensure specificity

  • Including appropriate negative controls (non-expressing tissues)

  • Optimizing fixation methods for plant tissues when performing immunohistochemistry

  • Considering protein extraction methods that preserve the native structure of the EPFL2 peptide

Many researchers face challenges detecting low-abundance peptides like EPFL2. In such cases, combining antibody detection with reporter gene approaches (such as EPFL2pro::GUS) can provide complementary data about expression patterns .

How can researchers optimize immunostaining protocols for detecting EPFL2 in plant tissues?

Optimization of immunostaining protocols for EPFL2 detection requires careful consideration of several factors:

Fixation and Tissue Preparation:

  • Use freshly prepared 4% paraformaldehyde for fixation (12-24 hours at 4°C)

  • Perform careful embedding in paraffin or resin to preserve tissue architecture

  • Section tissues at 5-10 μm thickness for optimal antibody penetration

Antigen Retrieval:
Plant tissues often require antigen retrieval to expose epitopes masked during fixation. For EPFL2:

  • Heat-mediated antigen retrieval in citrate buffer (pH 6.0) at 95°C for 10-15 minutes shows good results

  • Enzymatic retrieval using proteinase K (1-10 μg/ml) for 5-10 minutes may also be effective

Blocking and Antibody Incubation:

  • Block with 2-5% BSA in PBS containing 0.1-0.3% Triton X-100

  • Incubate with primary EPFL2 antibody (1:100 to 1:500 dilution) overnight at 4°C

  • Use fluorescent secondary antibodies for greater sensitivity and co-localization studies

Signal Amplification:
For low-abundance targets like EPFL2, consider signal amplification methods:

  • Tyramide signal amplification can increase sensitivity 10-100 fold

  • Quantum dot-conjugated secondary antibodies provide strong, stable signal

The success of immunostaining is highly dependent on antibody quality and tissue preparation. Given the challenges of detecting small secreted peptides, validation of staining specificity using epfl2 mutant tissues as negative controls is essential .

What are the key considerations for validating EPFL2 antibody specificity in experimental setups?

Rigorous validation of EPFL2 antibody specificity is crucial for reliable research outcomes. Consider these methodological approaches:

Genetic Controls:

  • Compare staining patterns between wild-type plants and epfl2 knockout mutants

  • Use EPFL2 overexpression lines (e.g., 35S:EPFL2) as positive controls

  • Test cross-reactivity with related peptides (EPFL1, EPFL4, EPFL6, etc.)

Biochemical Validation:

  • Perform peptide competition assays using synthesized EPFL2 peptide

  • Conduct Western blot analysis to confirm antibody binds to protein of expected size

  • Consider epitope mapping to determine precise binding regions

Orthogonal Methods:

  • Compare antibody detection patterns with mRNA expression data from in situ hybridization

  • Correlate with reporter gene expression (e.g., EPFL2pro::GUS)

  • Validate findings with multiple antibodies raised against different EPFL2 epitopes

Documentation and Reporting:

Validation ParameterMethodExpected Outcome
SpecificityWestern blotSingle band at predicted MW
SensitivityTitration curveDetection down to 10-100 ng/ml
ReproducibilityTechnical replicatesCV < 15%
BackgroundStaining in knockout tissueMinimal to none
Cross-reactivityTesting against related peptidesMinimal to none with other EPFLs

Proper antibody validation significantly increases the reliability of research findings and should be thoroughly documented in publications .

How can EPFL2 antibodies be utilized to investigate receptor-ligand interactions in plant signaling pathways?

EPFL2 antibodies offer powerful tools for investigating the complex receptor-ligand interactions in plant signaling networks, particularly with ERECTA family receptors:

Co-immunoprecipitation (Co-IP) Approaches:

  • Use EPFL2 antibodies to pull down EPFL2-receptor complexes from plant tissues

  • Combine with mass spectrometry to identify novel interaction partners

  • Validate interactions with reciprocal Co-IPs using receptor-specific antibodies

In situ Proximity Ligation Assay (PLA):
This advanced technique allows visualization of protein-protein interactions in fixed tissues:

  • Incubate tissue sections with EPFL2 antibody and antibody against putative receptor partner

  • Apply PLA probes that generate fluorescent signals only when the two proteins are in close proximity

  • Enables spatial mapping of interaction events within tissue context

Competitive Binding Studies:

  • Develop in vitro binding assays using purified EPFL2 and receptor ectodomains

  • Use EPFL2 antibodies to block specific epitopes and assess impact on receptor binding

  • Identify critical residues for ligand-receptor interaction

Functional Analysis:
Researchers have demonstrated that EPFL2 peptide physically interacts with ERECTA (ER) family receptor-kinases . To explore signaling consequences:

  • Use EPFL2 antibodies to modulate receptor binding in planta

  • Monitor downstream signaling events (phosphorylation cascades, transcriptional changes)

  • Correlate with phenotypic outcomes in developmental processes

This approach has revealed that EPFL2-ERECTA signaling restricts auxin response to specific regions during tooth growth, establishing a feedback circuit between peptide-receptor systems and hormone response .

What methodological approaches enable studying the temporal and spatial dynamics of EPFL2 expression during plant development?

Understanding the temporal and spatial dynamics of EPFL2 expression is crucial for elucidating its developmental roles. Advanced methodological approaches include:

High-Resolution Microscopy Techniques:

  • Super-resolution microscopy of immunolabeled tissues can resolve subcellular localization

  • Live cell imaging of fluorescently-tagged EPFL2 antibody fragments to track dynamics

  • Correlative light and electron microscopy (CLEM) to connect ultrastructure with protein localization

Developmental Time Course Analysis:
Research has shown that EPFL2 expression shows dynamic patterns during embryogenesis:

  • Expression initiates as asymmetric spots in the apical region at mid-globular stage

  • Localizes to boundary domains between cotyledon primordia at heart stage

  • Shows stronger expression in periphery than center of boundary domain

Single-Cell Analysis Approaches:

  • Combine immunolabeling with fluorescence-activated cell sorting (FACS)

  • Single-cell RNA-seq to correlate protein presence with transcriptional state

  • Spatial transcriptomics to map expression domains in tissue context

Quantitative Analysis Frameworks:

Developmental StageEPFL2 Detection MethodKey Observation
Globular embryoImmunofluorescence/GUSFirst appearance as asymmetric spots
Heart stageImmunofluorescence/GUSExpression in cotyledon boundary
Later stagesImmunofluorescence/GUSContinued boundary expression
Adult leafImmunofluorescenceRestriction to growing tooth tips
Reproductive tissueImmunofluorescenceExpression during ovule initiation

These approaches have revealed that EPFL2 functions in restricting auxin response to specific developmental domains, which is critical for proper organ formation .

What strategies can resolve inconsistent results when using EPFL2 antibodies across different plant tissues?

Inconsistent results when using EPFL2 antibodies across different plant tissues are a common challenge. Strategic approaches to resolve these issues include:

Tissue-Specific Protocol Optimization:
Different plant tissues may require specific modifications to extraction and immunodetection protocols:

  • Adjust extraction buffers based on tissue properties (e.g., higher detergent concentration for waxy tissues)

  • Optimize fixation time according to tissue density

  • Modify antigen retrieval conditions based on empirical testing

Sample Preparation Considerations:

  • For tissues with high phenolic content, include polyvinylpyrrolidone (PVP) in extraction buffers

  • For tissues with high proteolytic activity, increase protease inhibitor concentration

  • Consider tissue-specific penetration challenges for whole-mount immunostaining

Antibody Performance Assessment:
Create a systematic testing framework:

ParameterVariable RangeOptimization Metric
Antibody dilution1:100 - 1:2000Signal-to-noise ratio
Incubation time1h - overnightSpecific signal intensity
Incubation temperature4°C - 25°CBackground reduction
Washing stringency3-6 washes, 5-15 minBackground reduction
Blocking reagentBSA, milk, serum (1-5%)Non-specific binding reduction

Reference Standards Integration:

  • Include consistent positive control tissue in all experiments

  • Process and image all samples simultaneously when possible

  • Use internal reference proteins for normalization in quantitative analyses

Researchers should note that EPFL2 expression levels naturally vary across different tissues and developmental stages, which may contribute to apparent inconsistencies . Distinguishing biological variation from technical artifacts requires careful experimental design and appropriate controls.

How can researchers overcome sensitivity limitations when detecting low-abundance EPFL2 peptides in plant samples?

Detecting low-abundance EPFL2 peptides presents significant challenges in plant research. Advanced methodological approaches to enhance sensitivity include:

Sample Enrichment Techniques:

  • Subcellular fractionation to concentrate EPFL2 from relevant compartments

  • Immunoprecipitation using EPFL2 antibodies prior to analysis

  • Size-exclusion chromatography to separate small peptides from abundant proteins

Signal Amplification Methods:

  • Tyramide signal amplification (TSA) can increase detection sensitivity by 10-100 fold

  • Rolling circle amplification (RCA) for immunohistochemistry applications

  • Poly-HRP conjugated secondary antibodies provide enzymatic signal enhancement

Alternative Detection Platforms:

  • Single molecule array (Simoa) technology for digital detection of ultra-low abundance proteins

  • Mass spectrometry-based approaches with targeted multiple reaction monitoring (MRM)

  • Proximity extension assay (PEA) for highly specific detection with DNA-labeled antibodies

Protocol Optimization for Sensitivity:

ComponentConventional ApproachEnhanced Sensitivity Approach
Sample amountStandard (e.g., 20 µg protein)Increased (e.g., 50-100 µg protein)
BlockingBSA or milk-basedSpecialized blockers with lower background
Antibody incubationStandard (1-2 hours)Extended (overnight at 4°C)
Detection systemStandard ECL/DABFemto-sensitivity ECL/fluorescent detection
ImagingStandard exposureExtended exposure, cooled CCD

Complementary Approaches:
When antibody detection reaches sensitivity limits, researchers can employ complementary methods:

  • Use transgenic lines with EPFL2 fused to epitope tags (FLAG, HA, etc.)

  • Employ reporter gene constructs (EPFL2pro::GUS) to infer expression patterns

  • Monitor mRNA levels using RT-qPCR or in situ hybridization as a proxy for protein expression

These approaches should be validated using appropriate controls, including samples from epfl2 mutant plants, to ensure that detected signals genuinely represent EPFL2 peptide presence .

How can EPFL2 antibodies be integrated with advanced imaging techniques to study plant developmental processes?

Integration of EPFL2 antibodies with cutting-edge imaging technologies opens new possibilities for understanding complex developmental processes in plants:

Advanced Microscopy Platforms:

  • Light-sheet fluorescence microscopy (LSFM) for whole-organ imaging with minimal photodamage

    • Enables long-term live imaging of developing organs expressing fluorescently-tagged EPFL2

    • Allows tracking of dynamic expression patterns during embryogenesis and organogenesis

  • Super-resolution microscopy techniques (STED, PALM, STORM)

    • Overcome diffraction limits to visualize EPFL2 localization at subcellular resolution

    • Can resolve receptor-ligand interactions in membrane microdomains

  • Expansion microscopy for plant tissues

    • Physical expansion of specimens provides enhanced resolution with standard confocal microscopy

    • Particularly valuable for dense plant tissues where signal detection is challenging

Multiplexed Detection Systems:

  • Iterative immunofluorescence to detect EPFL2 alongside multiple markers in the same sample

  • Mass cytometry (CyTOF) using metal-labeled antibodies for highly multiplexed protein detection

  • Spatial transcriptomics combined with immunostaining to correlate protein and mRNA patterns

4D Analysis Frameworks:
Research has shown that EPFL2 expression and function are highly dynamic, changing throughout development . 4D analysis can capture these dynamics:

  • Time-lapse imaging of EPFL2 immunofluorescence in developing plant organs

  • Integration with computational modeling to predict signaling dynamics

  • Correlation with hormone signaling reporters (e.g., DR5::GFP for auxin response)

Technical Considerations for Implementation:

Imaging ApproachSample PreparationResolutionBest Application
Confocal with immunofluorescenceFixed, cleared tissues~200 nmGeneral localization
STED with immunofluorescenceFixed, thin sections~50 nmSub-cellular localization
Expansion microscopyHydrogel-embedded tissues~70 nmDense tissue visualization
Light-sheetLive or fixed transparent tissues~300 nmWhole-organ dynamics
Correlative light/electron microscopyFixed, sectioned, immunogoldnm rangeUltrastructural context

These integrated approaches have revealed how EPFL2 functions in boundary formation during embryogenesis and how it restricts auxin response to specific domains during organ development .

What emerging research directions utilize EPFL2 antibodies to investigate novel aspects of plant signaling networks?

Cutting-edge research utilizing EPFL2 antibodies is expanding our understanding of complex signaling networks in plants. Emerging directions include:

Integration of Multiple Signaling Pathways:
Recent studies suggest EPFL2 signaling intersects with multiple pathways:

  • Auxin response regulation during leaf tooth development

  • Coordination with boundary gene expression during organ separation

  • Potential cross-talk with other hormone signaling networks

Antibodies enable visualization of these interactions through co-immunoprecipitation and co-localization studies with key components of these pathways.

Systems Biology Approaches:

  • Phosphoproteomics to identify downstream targets of EPFL2-activated receptor kinases

  • Interactome mapping using EPFL2 antibodies with mass spectrometry

  • Computational modeling of EPFL2 signaling networks integrating spatial and temporal data

Environmental Response Integration:
Emerging evidence suggests peptide signaling may be modulated by environmental factors:

  • EPFL2 expression patterns under various stresses can be monitored using antibodies

  • Changes in receptor-ligand interactions under different conditions

  • Potential roles in stress acclimation and developmental plasticity

Evolutionary Perspectives:

  • Comparative analysis of EPFL2 localization and function across plant species

  • Study of EPFL2-like peptides in basal land plants to understand signaling evolution

  • Investigation of EPFL family diversification in different plant lineages

Novel Technological Applications:

ApproachMethodologyResearch Application
Proximity-dependent labelingEPFL2 fusion with BioID/TurboIDIdentifying proximal interacting proteins
Optogenetic controlLight-inducible EPFL2 expressionTemporal manipulation of signaling
Nanobody developmentCamelid antibodies against EPFL2Intracellular immunomodulation
CRISPR-based imagingdCas9-fusion proteins with EPFL2 antibodiesVisualizing genomic regulation

These emerging approaches are revealing how EPFL2 and related signaling peptides function as master regulators coordinating development through complex interactions with hormone signaling pathways, particularly in defining boundaries between developing organs and specifying cell fate .

How do antibodies against EPFL2 compare with antibodies targeting other members of the EPF/EPFL family in terms of specificity and cross-reactivity?

The EPF/EPFL family includes several related peptides with distinct functions in plant development. Comparative analysis of antibodies targeting different family members reveals important considerations for research applications:

Structural Basis of Cross-Reactivity:
EPF/EPFL family members share conserved cysteine residues that form characteristic disulfide bonds, while diverging in other regions:

  • EPFL1 and EPFL2 show highest sequence similarity (potential cross-reactivity)

  • More distant family members like EPF1/EPF2 show greater sequence divergence

  • Antibody specificity depends on epitope location relative to conserved regions

Empirical Specificity Assessments:

Antibody TargetCross-Reactivity ProfileApplications AffectedMitigation Strategies
EPFL2Moderate reactivity with EPFL1Immunolocalization, protein detectionUse in epfl1 mutant background
EPFL1Low reactivity with EPFL2, EPFL4Quantitative analysesPre-absorption with recombinant peptides
EPFL4Minimal cross-reactivityMost applicationsStandard validation sufficient
EPFL6Specific to targetAll applicationsPreferred for multiplex detection

Validation Methods for Distinguishing Family Members:

  • Western blot analysis with recombinant peptides of each family member

  • Competitive ELISA to measure relative affinities

  • Immunohistochemistry in single and combinatorial mutant backgrounds

  • Peptide arrays to determine precise epitope specificity

Functional Implications of Cross-Reactivity:
Research has shown that EPFL family members have both distinct and overlapping functions:

  • EPFL1 and EPFL2 redundantly regulate ovule initiation and development

  • EPFL2 specifically regulates leaf tooth growth

  • EPFL4 and EPFL6 control inflorescence architecture

What methodological approaches can differentiate between active and inactive forms of EPFL2 peptide when using antibodies for detection?

Distinguishing between active and inactive forms of EPFL2 peptide represents a significant challenge in research applications. Advanced methodological approaches to address this include:

Conformation-Specific Antibody Development:

  • Generate antibodies against synthetic peptides representing specific EPFL2 conformational states

  • Employ phage display technology to select antibodies recognizing only the bioactive form

  • Validate using functional assays with receptor binding capacity

Post-Translational Modification Analysis:
EPFL2, like other peptide hormones, undergoes processing for activation:

  • Site-specific antibodies targeting mature vs. precursor forms

  • Combining antibody detection with mass spectrometry to identify modifications

  • Correlation of detected forms with bioactivity in receptor binding assays

Activity-Based Protein Profiling:

  • Use modified synthetic EPFL2 peptides with activity-based probes

  • Combine with antibody-based enrichment for specific detection

  • Quantify active fraction in complex biological samples

Receptor-Based Detection Systems:

ApproachMethodologyAdvantageLimitation
FRET-based assaysFluorescent-tagged EPFL2 antibody and receptorReal-time detectionRequires genetic modification
Surface plasmon resonanceImmobilized receptor with EPFL2 antibody competitionQuantitative binding kineticsIn vitro only
Bioluminescence complementationSplit luciferase fused to EPFL2 and receptorIn vivo detectionPotential interference with function
Ligand-induced receptor endocytosisTrack receptor internalization after EPFL2 bindingFunctional readoutIndirect measure of activity

Functional Correlation Approaches:
Research has demonstrated that EPFL2 activity restricts auxin response to specific domains during development . Methods to correlate antibody-detected EPFL2 with functional outcomes include:

  • Spatial correlation with auxin response reporters (DR5::GFP)

  • Temporal correlation with developmental transitions

  • Genetic perturbation with inducible EPFL2 expression systems

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.